Fundraising FoxDolby Family Ventures — 2021 Investments
7 investments dated 2021 · listed companies and verified rows first · show all
Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.
BiotechDigital HealthMedical Devices
David Olson(Founder)David Olson Nick Haft(Founder)Nick Haft(Founder)
Co-investorsArtis VenturesBailey Venture PartnersCasa Verde CapitalGaingelsIaso VenturesNoetic+9 more
__Twitter.png)
Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases.
AI & Machine LearningBiotechMedical DevicesNew York, US
Martin Akerman, PhD(CEO & Co-founder)Martin Akerman(Founder)inMaria Luisa Pineda(Founder)in
Co-investorsDynamk CapitalHAWKTAILM12 (Microsoft's Venture Fund)Madrona Venture GroupRed Cell IncubationThird Kind Venture Capital
Paradromics develops a brain-computer interface (BCI) system, with FDA Breakthrough Device Designations for speech decoding and digital device control, and works with academic medical institutions on translational BCI research.
BiotechDeep TechHealthtechMedical DevicesAustin, US
Matt Angle(Founder and CEO)inRon Kelly(Director)Thomas Krummel(Director)Adam Kablanian(Director)
Co-investors15th RockAlpha EdisonAnthropy PartnersATEL VenturesCapital FactoryCloudStone Capital+27 more
Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
AI & Machine LearningBiotechDigital HealthMedford, US
Jerrold Rosenbaum(Co-Founder & Chair Emeritus, Massachusetts General Hospital (MGH) Department of Psychiatry)inJacob Hooker(Co-Founder & Chief Executive Officer)inPranav Tadi(Executive Officer)Stephen Haggarty, PhD(Co-Founder & Professor of Neurology, Harvard Medical School)Dick Simon, MBA(Co-Founder)
BoardRyan Katz(Director)in
Co-investorsBonaventure Equity, LLCHatteras Venture PartnersIter InvestmentsMission BiocapitalPalo Santo VCRoute 66 Ventures+4 more
Sepion develops advanced polymer separator technology for batteries and other applications including water separation and materials recovery.
CleantechDeep TechEnergyNew MaterialsSilicon Valley, US
Peter Frischmann(CEO & Co-Founder)inBrett Helms(CSO & Co-Founder)in
BoardRandy Chan(Director)
Co-investorsACVC PartnersAlumni VenturesCreative VenturesFine Structures VenturesFoothill VenturesGaingels+4 more
TripleBlind develops privacy and security software using quantum-safe and cryptographic methods, with two main products: Privacy Suite for HIPAA-compliant sharing of protected health data and SecuriKey, a software-only security module addressing account takeover attacks.
CybersecurityDigital HealthSaaSKansas City, US
Riddhiman Das(Executive Officer, Director)Greg Storm(Executive Officer, Director)inAndrew Krowne(Director)in
BoardThad Langford(Director)in
Co-investorsAlumni VenturesClocktower VenturesFlyover CapitalKCRise FundRolling Fun GPAccenture Ventures+5 more
Colorado aerospace and defense manufacturer of rocket engines, solid rocket motors, hypersonic and in-space propulsion systems.
Berthoud, US
Joseph A. Laurienti, Jr.(Executive Officer, Director, Promoter)Nicholas Doucette(Executive Officer)David Gregory(Executive Officer)
BoardStewart Alsop(Director)in
Co-investorsAlsop Louie PartnersAlumni VenturesRTX VenturesAlpha EdisonBlackRockEclipse+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.